Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scandinavian Candesartan Acute Stroke Trial
2004-002187-22Phase 3Terminated
- Sponsor
- Ullevål University Hospital
- Start
- Feb 2005
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of candesartan in brain infarction and brain hemorrhage (ICH), sponsored by Ullevål University Hospital. Primary endpoint: Clinical outcomes in acute stroke. Started Feb 2005; status: terminated.
02
Drugs
candesartan
03
Conditions
brain infarctionbrain hemorrhage (ICH)
Beyond the preview
Go deeper on 2004-002187-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002187-22.